🏛️ Verified NIH Record • Updated 2026-04-30
Comparing Two Ways to Manage Head and Neck Lymphedema (NCT05182229)
Comparing Two Ways to Manage Lymphedema in Head and Neck Cancer Survivors
🔵 Active, Not Recruiting Observational / Diagnostic 📋 Clinical Research Protocol Sponsor: Abramson Cancer Center at Penn Medicine
🩺 Plain-English Summary (8th-Grade Level)
This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.
Who can join: Review the eligibility criteria below.
Location: Jefferson Cherry Hospital Jefferson Health — Cherry Hill, New Jersey
Age range: 18 Years
🧪 Interventions in This Study
- Home-based (a hybrid model) CDT (OTHER)
- Clinic-based CDT (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- Jefferson Cherry Hospital Jefferson Health — Cherry Hill, New Jersey
- University of Pennsylvania — Philadelphia, Pennsylvania
- Jefferson Health — Philadelphia, Pennsylvania
- Jefferson Torresdale Hospital Jefferson Health — Philadelphia, Pennsylvania
- Temple University Hospital and Fox Chase Cancer Center — Philadelphia, Pennsylvania
- Asplundh Cancer Pavilion Jefferson Health — Willow Grove, Pennsylvania
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Head and Neck Cancer
- Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity — Boston, Massachusetts
- Imaging With a PET Agent for Detection of Cancers of the Head and Neck — New York, New York
- Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer — Miami, Florida
- ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy — Miami, Florida
- ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer — Bethesda, Maryland
- "QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer — Oklahoma City, Oklahoma
Explore by condition: All Head and Neck Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.